Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Louny – page 2

21 clinical trials in Louny, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Louny at a glance
21
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

21 trials in Louny

Open in trial search

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Hypertension

Not recruiting

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Hypertension

Not recruiting

Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5462
  • Sponsor:AstraZeneca AB

Dyslipidaemia

Not recruiting

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One
  • Sponsor:AstraZeneca AB

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Louny

What the registry says about research in the country

01 Cardiovascular Disease Management

Innovative research focusing on cardiovascular disease treatments, including studies of novel therapeutics for reducing major adverse cardiovascular events and improving patient outcomes.

  • Lipoprotein Management
  • Heart Attack Prevention
  • Stroke Risk Reduction

Advanced clinical investigations targeting specific cardiovascular biomarkers and their role in disease progression.

02 Heart Failure Research

Comprehensive studies examining new treatments for chronic heart failure, with particular attention to patients with reduced ejection fraction and kidney function impairment.

  • Combination Therapy Evaluation
  • Cardiac Function Improvement
  • Mortality Risk Reduction

Innovative approaches to managing heart failure symptoms and improving quality of life.

03 Metabolic Health Studies

Research initiatives addressing dyslipidemia and severe hypertriglyceridemia, investigating new therapeutic approaches for managing blood lipid levels.

  • Lipid Level Management
  • Cholesterol Reduction
  • Cardiovascular Risk Prevention

Cutting-edge treatments targeting metabolic disorders and their cardiovascular complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.